• roche logo
  • Roche_Woman_Hero_small.png

    cobas® 4800 HPV Test

    Choose the test with proven reliability and flexibility in reporting.

The cobas® 4800 HPV Test offers flexibility in reporting.

Choose from two reporting options with the cobas® 4800 HPV Test. 

The cobas® 4800 HPV Test is the only IVD high-risk HPV test with the flexibility to offer two reporting options, all in one run, from one patient sample:

  • 12 high-risk genotypes in a pooled result with individual genotyping of HPV 16 & HPV 18 
  • 14 high-risk genotypes as a pooled result


Use the cobas® 4800 HPV Test before or after cytology processing.

The cobas® 4800 HPV Test offers flexibility in cytology processing, as specimens can be processed directly from liquid-based cytology (LBC) vials. Collection vials can be directly loaded onto the cobas® 4800 System before or after cytology processing, eliminating the need to transfer aliquots to a secondary vial. 

The removal of a secondary vial reduces costs and biohazardous waste, in addition to saving the time and effort used to label the tube and aliquot the sample. As a result, primary vial loading decreases repetitive motions in the lab.  


Labs can use the same LBC vial for direct loading into the cobas® 4800 System for high-risk HPV (hrHPV) testing.

Choose the test that has proven reliability and performance.

The cobas® 4800 HPV Test performs reliably and consistently on primary vial specimens, regardless if cytology has been previously performed, providing confidence in the results.  


During clinical testing, the overall percentage agreement (OPA) in the entire population seen in samples that were tested from both a secondary vial (pre-cytology) and a primary vial was 98.8% when using the T2000 and 97.7% for the T3000 system.1


In addition, cytology processing using the T2000 or the T3000 system showed no evidence of cross-contamination when using the primary vial method.1   

Based on these results, the primary vial testing option offers the lab flexibility in its workflow, while still providing accurate patient results. 



Reduce pipetting time and labor.  

The primary vial method decreases repetitive motions in the lab, such as pipetting.  

With the primary vial method, labs will benefit from:

  • Reduced processing time and labor 
  • Reduced aliquoting and labeling
  • Reduced repetitive motions that lead to fatigue
  • Reduced risk of errors due to fatigue
  • Reduced biohazardous waste production
  • Reduced cost by eliminating need for additional consumables

  • Acronyms:


1. Rao A, Young S, Krevolin M, Sun R, Purner MB, Sharma A, Behrens CM. 2012 Cancer Cytopathol. Jun 20. Vol120(3).